Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1489-1499

  Liu, Wen Jing ^a   Ma, Lan Qing ^b   Liu, Wei Hua ^a   Zhou, Wei ^a   Zhang, Ke Qin ^a   Zou, Cheng Gang ^a  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DRINKING WATER; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; HOMOCYSTEINE; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRIBBLES RELATED PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; LIVER; MALE; MEDIATOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

EID: 79953665989     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.052     Document Type: Article

References (47)

1. Barthel A, Schmoll D: Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 2003, 285:E685-E692 (Pubitemid 37176418)
2. Bollen M, Keppens S, Stalmans W: Specific features of glycogen metabolism in the liver. Biochem J 1998, 336(Pt 1):19-31 (Pubitemid 28532556)
3. Aiston S, Hampson LJ, Arden C, Iynedjian PB, Agius L: The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes. Diabetologia 2006, 49:174-182 (Pubitemid 43151629)
4. Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001, 24:533-538 (Pubitemid 32198426)
5. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino RB Sr, Wilson PW: Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001, 24:1403-1410 (Pubitemid 33716428)
6. De Pergola G, Pannacciulli N, Zamboni M, Minenna A, Brocco G, Sciaraffia M, Bosello, Giorgino R: Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women. Diabetes Nutr Metab 2001, 14:253-258 (Pubitemid 34026505)
7. Fonseca VA, Fink LM, Kern PA: Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 2003, 167:105-109 (Pubitemid 36255641)
8. Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR: Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 2007, 76:1-5 (Pubitemid 46240359)
9. Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, Magni F, Sandoli EP, Lucotti P, Costa S, Fermo I, Galli-Kienle M, Origgi A, Margonato A, Piatti P: Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004, 151:483-489 (Pubitemid 39430267)
10. Li Y, Jiang C, Xu G, Wang N, Zhu Y, Tang C, Wang X: Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes 2008, 57:817-827
11. Najib S, Sanchez-Margalet V: Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001, 27:85-91 (Pubitemid 32771460)
12. Najib S, Sanchez-Margalet V: Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 2005, 34:119-126
13. Ron D, Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529 (Pubitemid 46985379)
14. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, Cheung P, Merali S: Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008, 57:2438-2444
15. Eizirik DL, Cardozo AK, Cnop M: The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008, 29:42-61 (Pubitemid 351252746)
16. Wang D, Wei Y, Schmoll D, Maclean KN, Pagliassotti MJ: Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 2006, 147:350-358 (Pubitemid 43004288)
17. Mata J, Curado S, Ephrussi A, Rorth P: Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis. Cell 2000, 101:511-522
18. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H: TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 2005, 24:1243-1255 (Pubitemid 40516607)
19. Zou CG, Cao XZ, Zhao YS, Gao SY, Li SD, Liu XY, Zhang Y, Zhang KQ: The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor I. Endocrinology 2009, 150:277-285
20. Du K, Herzig S, Kulkarni RN, Montminy M: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577 (Pubitemid 36682889)
21. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, Weitz JI, Austin RC: Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999, 94:959-967 (Pubitemid 29361827)
22. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima S: Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 2001, 276:35867-35874
23. Dayal S, Lentz SR: Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 2008, 28:1596-1605
24. Postle AD, Bloxham DP: The use of tritiated water to measure absolute rates of hepatic glycogen synthesis. Biochem J 1980, 192:65-73 (Pubitemid 11207912)
25. Vitvitsky V, Dayal S, Stabler S, Zhou Y, Wang H, Lentz SR, Banerjee R: Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia. Am J Physiol Regul Integr Comp Physiol 2004, 287:R39-R46 (Pubitemid 38856309)
26. Hansen LK, Albrecht JH: Regulation of the hepatocyte cell cycle by type I collagen matrix: role of cyclin D1. J Cell Sci 1999, 112(Pt 17):2971-2981 (Pubitemid 29430042)
27. Lisbona F, Rojas-Rivera D, Thielen P, Zamorano S, Todd D, Martinon F, Glavic A, Kress C, Lin JH, Walter P, Reed JC, Glimcher LH, Hetz C: BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol Cell 2009, 33:679-691
28. De Souza AT, Dai X, Spencer AG, Reppen T, Menzie A, Roesch PL, He Y, Caguyong MJ, Bloomer S, Herweijer H, Wolff JA, Hagstrom JE, Lewis DL, Linsley PS, Ulrich RG: Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice. Nucleic Acids Res 2006, 34:4486-4494 (Pubitemid 44567048)
29. Brady MJ, Saltiel AR: The role of protein phosphatase-1 in insulin action. Recent Prog Horm Res 2001, 56:157-173
30. Patel S, Doble B, Woodgett JR: Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans 2004, 32:803-808
31. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001, 107:1263-1273 (Pubitemid 32494543)
32. Namekata K, Enokido Y, Ishii I, Nagai Y, Harada T, Kimura H: Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J Biol Chem 2004, 279:52961-52969 (Pubitemid 40051794)
33. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M: PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 2004, 10:530-534 (Pubitemid 38667913)
34. Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ, Liu ZX, Lee HY, Distefano A, Samuel VT, Zhang D, Cline GW, Handschin C, Lin J, Petersen KF, Spiegelman BM, Shulman GI: Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Natl Acad Sci U S A 2008, 105:19926-19931
35. Kehrer JP, Biswal SS, La E, Thuillier P, Datta K, Fischer SM, Vanden Heuvel JP: Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem J 2001, 356:899-906 (Pubitemid 32588464)
36. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138 (Pubitemid 32867868)
37. Woo CW, Siow YL, O K: Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway. Arterioscler Thromb Vasc Biol 2006, 26:1043-1050 (Pubitemid 43732110)
38. Crosson SM, Khan A, Printen J, Pessin JE, Saltiel AR: PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest 2003, 111:1423-1432 (Pubitemid 36554713)
39. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A: Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007, 47:142-156 (Pubitemid 46830723)
40. Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, Kruger WD: Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J 2009, 23:883-893
41. Farese RV, Sajan MP, Standaert ML: Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med (Maywood) 2005, 230:593-605
42. Cross DA, Watt PW, Shaw M, van der Kaay J, Downes CP, Holder JC, Cohen P: Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett 1997, 406:211-215 (Pubitemid 27156992)
43. He L, Simmen FA, Mehendale HM, Ronis MJ, Badger TM: Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane: role of TRB3 in inhibition of Akt/protein kinase B activation. J Biol Chem 2006, 281:11126-11134 (Pubitemid 43855537)
44. Winston GW, Reitz RC: Chronic ethanol ingestion and glycogen metabolism in male and female rats. Adv Exp Med Biol 1980, 132:569-577
45. Van Horn CG, Ivester P, Cunningham CC: Chronic ethanol consumption and liver glycogen synthesis. Arch Biochem Biophys 2001, 392:145-152 (Pubitemid 32721624)
46. Lentz SR, Haynes WG: Homocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med 2004, 71:729-734
47. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183 (Pubitemid 32867880)